FILTRIX Logo FILTRIX Find Your Edge →
← All insights

$HELP — what the base rate says

$HELP — what the base rate says

Helus Pharma sent out an invitation on Sunday afternoon. It says the company will present topline results from its Phase 3 APPROACH study of HLP003, an adjunctive treatment in major depressive disorder, on November 16, 2026.

That is today, and $HELP is +12.51% before the bell.

Read the notice for what it contains. A date. A drug name. A reminder that HLP003 has FDA Breakthrough Therapy Designation, which it already held when the notice went out. What it does not contain is a number from the study, and no later release is in the feed.

So the morning's buyers are paying up for the one piece of a Phase 3 that cannot miss its endpoint: the calendar entry.

For contrast on the same tape: #DRTS is +13.60% with numbers in the release. Interim data from its recurrent glioblastoma trial, eight treated patients all alive at a 6.9-month median follow-up, a 100% objective response rate in the six evaluable. Small and interim, but there is something there to argue with. A calendar entry can't be argued with at all.

What the data showed

  • $FCDH -32.74% Forcendra Holding Limited
  • $DVLT -31.67% Datavault AI Inc. mcap $57M · float 971M shares · sector: SERVICES-BUSINESS SERVICES, NEC
  • $ZBAO -30.67% Zhibao Technology Inc. mcap $5M · float 453M shares
  • $FCUV -29.38% Focus Universal Inc. mcap $7M · float 879,330 shares · sector: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
  • $TGHL -28.28% The Growhub Limited mcap $9M · float 13M shares
  • $SHFS -27.06% SHF Holdings, Inc. mcap $31,141 · float 919,166 shares · sector: FINANCE SERVICES
  • $MBOT -26.44% Microbot Medical Inc. mcap $66M · float 67M shares · sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • $ONFO -24.00% Onfolio Holdings, Inc. mcap $2M · float 2M shares · sector: SERVICES-COMPUTER PROCESSING & DATA PREPARATION
  • $NX -19.13% Quanex Building Products Corporation mcap $879M · float 33M shares · sector: ROLLING DRAWING & EXTRUDING OF NONFERROUS METALS
  • $SMMT -18.73% Summit Therapeutics Inc. mcap $11.3B · float 145M shares · sector: PHARMACEUTICAL PREPARATIONS

This ticker has too few prior gap-up sessions to compare against anything, and that is worth knowing before the open. Check the sample size on FILTRIX.net before a pre-market gap talks you into seeing a pattern.

Find Your Edge on FILTRIX →